Evidence Library
phase_2_clinical_study · 2013

ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density

Dahan A|et al. · Molecular Medicine
moderateDOI · 10.2119/molmed.2013.00122PMID · 24136731Verified
Plain-English summary

Reported improved selected symptoms and increased corneal nerve-fibre density after treatment.

Population
Patients with sarcoidosis-associated small fiber neuropathy
Intervention
ARA-290
Outcomes measured
Symptoms|corneal nerve fiber density
Key findings
Symptom and nerve-structure signal.
Limitations
Small exploratory study|Surrogate nerve-fibre outcomes|Needs larger confirmation
Risk of bias
Moderate.
Citation
Dahan A|et al. (2013). ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Molecular Medicine. https://doi.org/10.2119/molmed.2013.00122
Linked peptides in the PeptiBrief database
ImportantPeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.